Deep sequencing has recently emerged as a powerful alternative to microarrays for the highthroughput profiling of gene expression. In order to account for the discrete nature of RNA sequencing data, new statistical methods and computational tools have been developed for the analysis of differential expression to identify genes that are relevant to a disease such as cancer. In this paper, it is thus timely to provide an overview of these analysis methods and tools. For readers with statistical background, we also review the parameter estimation algorithms and hypothesis testing strategies used in these methods.
Introduction
In the past decade, deep sequencing has emerged as a power ful alternative to microarrays for the highthroughput profil ing of gene expression. Comparing with microarrays, RNA sequencing (RNAseq) possesses a number of technological advantages such as a wider dynamic range and the freedom from predesigned probes. [1] [2] [3] It also comes with a unique data feature as discrete sequencing reads. In order to account for this unique data feature, statistical methodologies and computational algorithms have been developed based on various data distributional assumptions such as Poisson, nega tive binomial, beta binomial, (full or empirical) Bayesian, and nonparametric. 4-16, For researchers who are new to the analysis of RNAseq data, in this paper we provide an introductory overview of the methods and software available for the differential expres sion analysis (DEA) of RNAseq data when the analysis goal is to identify genes that are relevant to a disease such as cancer. 1, 17, 18 In addition, for those who are interested in the statistical aspects of these methods, we also provide an overview of their parameter estimation algorithms and hypothesis testing strategies. The overview of these statistical aspects in our paper provides a unique contribution to the review literature on RNAseq DEA methods. 3, [18] [19] [20] [21] [22] [23] For read ers who are interested in a performance comparison of RNA seq DEA methods, they can refer to a large body of such papers in the literature. [20] [21] [22] [23] The rest of the paper is organized as follows. In the Notation and Normalization Methods section, we intro duce the unified notations used for the methods reviewed in our paper and touch on the normalization methods typically used to preprocess RNAseq data before DEA. In the Statistical Modeling of RNAseq Data section, we review the statistical modeling RNAseq DEA catego rized by the distributional assumptions such as Poisson, [4] [5] [6] negative binomial, 7-10 beta binomial, 11, 12 Bayesian, 13, 14 and nonparametric. 15, 16 All reviewed methods directly work with genelevel count data for DEA and have available R packages. For interested readers with advanced statistical knowledge, the parameter estimation algorithm for each method is presented separately in a text box, and the typi cal statistical testing frameworks that have been proposed for RNAseq DEA are reviewed in the Statistical Testing section. Finally, computational tools implemented for the reviewed methods are summarized in Table 2 . We note that the methods reviewed in this paper are not an exhaustive collection of available methods in the literature. Rather, we reviewed a list of most commonly used categories of model ing assumptions and included a few representative methods for each category, to help researchers who are new to the field orientated and started in the still evolving literature on this topic.
Notation and Normalization Methods
Notation. RNAseq data for G genes and N samples can be described by a G × N matrix y. Each entry y gi (g = 1, …, G, i = 1, …, N) represents the count of sequencing reads for gene g in sample i. For a given g and i, y gi is a nonnega tive integer representing the number of reads mapped to gene g in sample i. For succinctness, we also use notations "⋅" for summations, eg, y y y y and . We use X to represent an N × P design matrix, where P is the number of covariates. For instance, x ip can be an indicator variable of disease status, taking a value of 0 for a normal sample and a value of 1 for a tumor sample. When comparing K groups of samples, C k represents the collec tion of indices of the samples in group k (k = 1, …, K), that is, C k = {i: x i = k}. Each sample can only belong to one group.
Normalization methods. Similar to microarray data, RNAseq data are also prone to nonbiological effects due to the experimental process. Consequently, these effects need to be adjusted before any further data analysis. 24 One major source of nonbiological effects is sequencing depth, which can be adjusted by rescaling the sequenc ing counts with factors that mimic sequencing depth. 25 Reads per kilobase per million reads (RPKM) is a simple adjustment that considers gene counts standardized by the gene length and the total number of reads in each library as expression values. 17, 26 More sophisticated adjustment factors, including trimmed mean of Mvalues (TMM), 27 DESeq size factor, 28 and quantilebased normalizations such as upper quartile normalization, 18 are given in Table 1 4 developed an R package, DEGseq, to identify differentially expressed (DE) genes with an MAplotbased approach. Langmead et al. 5 incorporated cloud computing in their method called Myrna.
Modeling. In a Poisson model, one assumes that Y gi , the number of reads mapped to gene g in sample i, follows a Poisson distribution, y gi ∼ Poisson(µ gi ). µ gi is the rate para meter for gene g in sample i, which equals both the mean and the variance of the read counts. The probability mass function is:
and E(Y gi ) = µ gi and Var(Y gi ) = µ gi . The association of µ gi with the same sample group can be described by a loglinear model as follows:
where d i represents the sequencing depth of sample i and
is assumed for generality. Let β g be the expres sion level of gene g and γ g be the association of gene g with the covariate. For hypothesis testing, γ g1 = … = γ gK = 0 indi cates that the expression of gene g is not associated with the sample group. In the case of two sample group com parison, if γ g = 0, then gene g is not DE between the two sample groups. . However, instead of using the maximum likelihood estimate of the sequencing depth in sample i, the authors sought for a set of genes, denoted by S, that are not DE to estimate sequencing depth in sample i: S is set to be the genes whose GOF g values are in the (ε, 1 -ε) quantile of all GOF g values. Li and others used ε = 0.25 in their study. 6 The objective is to test H 0 :
and score statistics were proposed to perform the testing. For a twogroup or multiplegroup covariate, the score sta tistic for gene g is With accumulating empirical data (especially with the data available for groups of multiple biological samples), researchers began to observe that in a group, the betweensample variation of sequencing reads for a gene often exceeds the mean. 17, 23, 33 This excessive variation that cannot be explained by the Poisson model is called overdispersion. Extensions of the classic Pois son model have been proposed in order to accommodate such overdispersion, including the twostage Poisson models 34 and the generalized Poisson model.
35
Negative binomial. Overview. A class of models based on the negative binomial distribution assumption has been developed in order to accommodate the overdispersion among biological replicate data. 8, 9, 33, 36 Robinson and Smyth 33 used the conditional maximum likelihood (CML) to estimate the dispersion param eter-a measure of the excessive variance that a Poisson model does not incorporate-when assuming a common dispersion parameter across genes. They compared the CML method with alternative estimation methods based on pseudolikelihood, quasi likelihood, and conditional inference. [37] [38] [39] In a followup paper, 36 they also extended the model to allow for genespecific dispersion parameters and proposed to estimate the dispersion parameters by maximizing a weighted conditional likelihood with empiri cal Bayesian approximation. Details of their method, edgeR, can be found in Robinson and Smyth. 33, 36 edgeRun is based on the same model as edgeR but it uses an unconditional exact test to achieve more power while paying the price of computational time. 40 Anders and Huber 8 proposed a method called DESeq also under the negative binomial assumption. They advocated the use of a robust estimate of normalization factors for the esti mation of dispersion parameter and a local regression to obtain smooth function for each group on the graphs of expected pro portions vs sample variances. DESeq2 was developed in the study by Love et al. 9 as a successor of DESeq. It employs a number of new modeling features, such as the use of a shrunken fold change and a shrunken dispersion estimation method, to further improve the model performance. Di and others 10 proposed a method, NBPSeq, using a negative binomial power distribu tion instead of a regular negative binomial distribution. They
and φ is common across genes while α helps to accommodate the overdispersion. φ and α are estimated by maximizing condi tional loglikelihood, 41 conditional on the total gene counts for each gene g. An exact test modified for negative binomial power distribution is used for hypothesis testing. More details can be found in the study by Di et al. 10 Modeling. The model setup for negative binomial is to assume y gi ∼ negative binomial (µ gi , φ g ). The dispersion para meter, φ g , accounts for the sampletosample variability, which is usually assumed to be common across samples. There are various estima tion methods for this model assumption. More specifically, the negative binomial probability mass function is written as
where
Hypothesis test ing is set up as H 0 : no difference either between the expected normalized expression of gene g in groups or between the pro portion of reads that are gene g in groups.
Algorithm overview 2: overdispersion
Then,
One substitutes back µ gi , y gi , α = φ g -1 , and β = µ gi φ g , a gamma-Poisson mixture can be viewed as a negative binomial, see Equation (3.2.1).
Negative binomial can be derived as a gamma-Poisson mixture model (subscripts g's and i's are omitted for brev ity), under the assumption that technical replicates follow a Poisson distribution, and biological replicates follow a gamma distribution, with the latter accommodating the overdispersion observed in empirical data. that is gene g in group k and λ gi is the proportion of the total reads that is gene g in sample i.
Under the assumption of genewise (or tagwise in the original paper) dispersion, φ g is estimated by maximizing a weighted conditional loglikelihood, WL(φ g ):
where α is the weight given to the common likelihood, l C ; the maximum estimator of WL(φ g ) is denoted by φ  
The approximation method is selected as a direct estimate of φ g is difficult because of the lack of a con jugate prior for φ in negative binomial model. Details are given in the study by Robinson and Smyth. 33 In the study by Robinson and Smyth, 36 the overdisper sion parameter is assumed to be common across all genes (ie, φ g = φ). To estimate the shared dispersion parameter with and without equal library size, the authors proposed to use the CML and quantileadjusted CML (qCML) as follows.
In a special case where m i = m for i ∈ C k where C k = {i:
and Y gi 's evidently become identically distributed, and the maximum likelihood estimator (
was proposed. The function is as follows:
In the case of different m i in group k, the MLE of λ gk(i) depends on φ (ie, maximum likelihood estimation of the two parameters proceeds jointly). As a result, an approximate approach called qCML was proposed to equate the library sizes. The quantileadjusted pseudo data supposedly allows one to use a common likelihood l C (φ) to estimate an accurate estimate of φ. Specifically, let m m
, where m* is the geometric mean of the library sizes. Then, the observed data could be adjusted as if they were all sampled as identically distributed negative binomial (m*λ, φ). Hypothesis testing is set up as H 0 : λ g1 = λ g2 , in other words, no difference in proportion of gene g in samples between group 1 and group 2.
Algorithm overview 4: Anders and Huber's 8 DESeq

Algorithm overview 5: Love et al.'s 9 DESeq2
The read count y gi is modeled by a GLM of negative bino mial distribution with a log link:
The mean µ gi is the proportion of reads for gene g in sample i, λ gk(i) , scaled by a normalization factor, m i . The variance σ gi 2 is µ ν
, where ν gk(i) is assumed to be a per gene raw variance, a smoothing function of λ g and k. The use of the smoothing function can help stabi lize the variance estimates especially when the number of samples is small. For the estimation of the normalization factor (which is referred to as the size factor by Anders and Huber), m i , for each sample, the authors noted that highly DE genes are more likely to be influential on total count and so the median of the ratios of counts should be used for more robustness:
Since λ gk(i) is proportional to the expected value of the unknown proportion from gene g in group k, it is estimated by the average of counts from all samples in group k with a common scale.
where M k is the total number of replicates for group k. The sample variances with the common scale are calculated as:
In the case of a sufficiently large number of M k , one can see w gk -z gk as the unbiased estimator of the raw variance ν gk . In the case of a small number of M k , local regression for a smooth function w k (λ) on the graph of ( , DESeq2 allows the normalization factors to be gene specific (m gi ), rather than being fixed across genes (m i ). The estimation of m gi is implemented in their new R packages. 9 When modeling dispersion parameters, a large varia tion in estimates usually arises because of small sample sizes. DESeq2 proposed to pool genes with similar average expression together for the estimation of dispersions. To do this, one first separately estimates dispersion with maximum likelihood. Then, one identifies a location parameter for the distribution of the estimates by fitting a smooth curve dependent on average normalized expressions, before finally shrinking genespecific dispersions to the fitted curve using an empirical Bayesian approach. The authors stated that this procedure is more superior than DESeq.
In order to avoid identifying differential expressions in genes of small average expression, fold change estimation is shrunken toward 0 for genes with insufficient information by employing an empirical Bayesian shrinkage. The proce dure is as follows: (1) obtain the maximum likelihood esti mates for the log fold changes from the GLM fit, then (2) fit a normal distribution with mean 0 to the estimates, and (3) use that as the prior for a second GLM fit. The maximum a posterior and the standard error for each estimate are the products of this procedure and will be used for the calcula tion of Wald statistics for DEA.
DESeq2 computes a threshold, η, to filter genes based on their average normalized expressions. The threshold is calculated for maximizing the number of genes with a user defined false discovery rate. The authors claimed that this filtering step effectively controls the power of detecting DE genes. The null hypothesis becomes |β gp | # η where β gp is the shrunken log fold change.
Finally, the method provides a way to diagnose outli ers using the Cook's distance from the GLM within each gene, C d . Samples are flagged with C d $99% quantile of an F distribution with degrees of freedom as the number of parameter, P, and the difference in the number of samples and the number of parameter, N -P. When there is a large num ber of replicates available, influential data can be removed without removing the whole gene; however, when there is a small number of replicates, the entire gene with influential points should be removed from the analysis to preclude bias. More details on DESeq2's features can be found in the study by Love et al. 9 In conclusion, DESeq2 is recommended by its authors as an improved solution to perform differential analysis because it adopts many competitive features. beta binomial. Overview. A betabinomial model is another alternative distribution to accommodate overdisper sion. 11, 12, 42 The betabinomial distribution has been used in the study by Baggerly et al. 11 to account for both between library and withinlibrary variations. The authors assumed that the true proportion of gene g within a library i, θ gi , is libraryspecific and follows a beta distribution: θ gi ∼ Beta(α, β), and that the count Y gi given θ gi follows binomial (m i , θ i ). Zhou et al. 12 proposed a method, BBSeq, which also assumes a beta binomial distribution and models the proportions of gene g within sample i with a logistic regression. To estimate overdis persion parameters, BBSeq either treats the parameter as free and maximizing likelihood directly, or estimates the para meter through modeling the meanoverdispersion relationship.
Modeling. In a betabinomial model, y gi is converted from the count of gene g in sample i, to proportion, θ gi where
The model is constructed as:
where β g is a vector of the regression coefficients for sample cova riates and is the parameter for hypothesis testing; θ g. is a vector consisting of the proportion of gene g for sample i through N.
With the betabinomial distribution, we are no longer working with a log link but a logit link. θ gi ∼ Beta with E(θ gi ) = logit -1 (X β g ) and var(θ gi ) = φ g E(θ gi )(1 -E(θ gi )), where φ g is the dispersion parameter. The hypothesis test is constructed as H 0 :
, where β gC K denotes the estimated coefficient of the indica tor variable with 1 for samples in group k and 0 otherwise. bayesian and empirical bayesian. Overview. RNA seq DEA can be modeled in Bayesian framework using various parametric and nonparametric priors. Van de Wiel et al. 13 proposed a Bayesian method, ShrinkSeq, which either assumes an informative prior for the overdispersion such as the Dirac-Gaussian prior or estimates one with the empirical Bayesian approach. An empirical Bayesian approach differs from a fully Bayesian approach in that it borrows informa tion from data to elicit priors for overdispersion param eters. For estimating posteriors, Van de Wiel and others 13 adapted the use of integrated nested Laplace approxima tions, a method that only considers marginal posteriors, but adds a direct maximization of marginal likelihood to allow information sharing from joint posteriors. They further sug gested that the use of informative priors for shrinkage, as in ShrinkSeq, can ensure stability and accommodate multi plicity correction. They also suggested that shrinkage should be applied not only to overdispersion parameters but also to the regression coefficient parameters. baySeq, proposed by Hardcastle and Kelly, 14 constructs the data with tuples grouping genes together based on the study of interest. The distribution of a tuple shares the parameters of some prior distribution so that one can consider many hypotheses for testing beyond two group comparison. The method assumes a negative binomial distribution from the data. baySeq first estimates the empirical distribution on the set of parameters for null and alternative models with the quasilikelihood approach. Then, it estimates the prior probabilities starting from a prior followed by an iterative process updating the priors until convergence. The authors suggested using a log posterior probability ratio of DE for DEA and noted that the posterior probability of DE for each individual model can be conveniently summed up for hypothesis testing.
Modeling. A Bayesian GLM for RNAseq can be set as: Each parameter has its respective informative prior and one has to specify priors conditional on the model of interest as well as the prior itself to reach the posterior probability. For testing, a null hypothesis of β g # prior under the null is used.
Algorithm overview 6: Van de wiel et al.'s 13 ShrinkSeq
ShrinkSeq assumes that α is the unknown hyperparameter from a collection of all unknown hyperparameter vectors A. It uses a direct maximization of the marginal likelihood method for the estimation of A; this method is a modified version of INLA. 43 The procedure of finding α is shown below and is said to be analogous to the EM algorithm: The subscripts of p, ie, -1, 0, and 1, indicate the loca tions. For example, Dirac mass on 0 is denoted as δ 0 . Con sidering the p as probability where p -1 , p 0 , and p 1 sum up to 1, then p 0 = 1 -p -1 -p 1 . µ −1 , 0, µ 1 . 0. Priors with positive mass on zero were intentionally selected because it reflects the nonDE condition. For more details on priors, please refer to the study by Van 
… … … …
, which is the count in tuple t for sample i, m i is the library size. The posterior probability of model given data is:
Suppose that a sample A i is in the set E q where the count of this sample at a particular tuple t is y it , which follows a negative binomial(µ it , ϕ q ) (θ q = (λ q , ϕ q )). The mean count µ it is a product of the library size scaling factor, m i , and the proportion of reads in set E q , λ q . We have: baySeq first estimates the empirical distribution on the set of parameters for null and alternative models through sampling from a negative binomial distribution and a quasilikelihood approach. 38 Then, it estimates the prior probabilities starting from a prior followed by an iterative process updating the pri ors until convergence. For detailed steps, please refer Hard castle and Kelly.
14 Hypothesis testing can be easily denoted with the tuple system, for instance a twogroup case,
and Nonparametric. Overview. In this section, we discuss two nonparametric methods for RNAseq DEA by Li and Tib shirani 15 and Tarazona et al. 16 In SAMseq, Li and Tibshirani 15 calculated a modified twosample Wilcoxon statistic using the ranked counts for twogroup comparison. 44 The authors proposed two resampling strategies for producing equal sequencing depths of the samples: downsampling and Pois son sampling, and also suggested that ties can be broken by inserting a small random number in resampling. NOISeq by Tarazona et al. 16 first used pseudocounts corrected by the library size m k(i) under two conditions (K=2) to calculate logratio (M) and absolute value of difference (D). Then, a test statistic is derived from M and D with a null hypothesis of no differential expression; in other words, M and D are no different than ran dom variables either estimated from the real or simulated data.
Modeling. The two nonparametric methods discussed here are explained separately in the test boxes, as they each has a unique model setup.
Algorithm overview 8: Li and tibshirani's 15 SAMseq
To use SAMseq, one ranks the counts of gene g across sam ples and denotes the ordered counts as y y
. If needed, resampling strategy may be used to fulfill the requirement of equal sequencing depths of samples in Wilcoxon test.
In the case of a sufficient minimal sequencing depth, the authors proposed a downsampling strategy where one first identifies the smallest sequencing depth, denoted as m min , where m min = min(m 1 , …, m N ) and keeps this list of counts while resampling lists of counts for all other samples with the sequencing depth, m min . Every count is randomly sampled with a success probability of m min / m i and failure probability of its complement, ie, the resa mpled count is Small ran dom numbers are introduced into the resampling process to break ties, as well as multiple resampling to ensure stability. Poisson sampling is generally preferred based on the simula tion. 15 In cases where m i is unknown, one could use normal ization methods to estimate. Differential expression of gene g is identified based on a comparison of the ranks of gene g between the two sample groups.
In NOISeq, for each y gk(i) , the count of gene g in sample i from group k, the correction method for library size, m k(i) , is the sum of counts over all genes for the ith sample repli cate in condition k. Null hypothesis: L and D values are no different than noise if no DE. Probability distribution for random vari ables L* and D* are either estimated from real data or simu lated data and are used for the noises. One then obtains the probability of DE as: Note that log ratio is in absolute term because either direction indicates DE. See the study by Tarazona et al. 16 , for more details.
statistical testing
After performing parameter estimation for a statistical model, significance of differential expression can be assessed compar ing the expression of gene g among K groups. Assume that λ gk(i) is the expression level of gene g in sample i belonging to sample group k. φ g is the dispersion parameter. DE tests are proposed below for the null hypothesis (H 0 ):
In parametric regime, one can employ classic log likelihood ratio test.
In absence of overdispersion,
where l g denotes the loglikelihood function for the gth
λ 0 denote the MLE of biologi cal and experimental effects under the full model and null model, respectively.
An exact test for negative binomial, analogous to the Fisher's exact test, is used by methods, such as edgeR and DESeq. By conditioning on the total sum, one can calculate the probability of observing counts as extreme or more extreme than what is really obtained, resulting in an exact Pvalue. Note that a sum of gene counts from all replicates in each group that is either too large or too small indicates a differential expres sion, so a twosided test is used.
A score statistic is used by PoissonSeq, which tests for the significance of the association of gene g with expression of groups. In the context of gene count with unknown dispersion parameters, a score test is as follows: where M denotes a model. Posterior probability of DE to non DE ratio is often used. The choice of a testing strategy is a decision that often depends on the chosen method and other factors such as sam ple size. With a small sample size, the largesample approxi mations based on the Wald test, score test, and likelihood ratio test are questionable and an exact test is usually preferred. 36 We summarize testing strategies that are plausible for each method in Table 2 .
Finally, almost all the methods we mentioned in this paper use standard approaches for multiple hypothesis correc tion to control false discoveries. 45, 46 PoissonSeq is an exception that builds its own estimation of false discovery rate (FDR) from a permutation test. Permutation test calculates a score test per gene, S g , for H 0g vs H ag , each time when the outcome is permuted. For B permutations, the same procedure is applied to calculate null statistics Note that I{π 0g , t} = I{π 1g $ t} for small t of interest.
conclusion
RNAseq data analysis is a relatively new and rapidly growing research area. The statistical model used for sequencing data has been evolving. The first proposed Poisson distribu tion has become obsolete because it fails to accommodate commonlyobserved overdispersion in RNAseq data. In a parametric framework, the negative binomial distribution is the most common assumption for modeling the marginal distribu tion due to the technical and biological variations. 8, 9, 33, 36 Other available methods that account for overdispersions include the generalized Poisson distribution, 35 negative binomial power distribution, 10 and betabinomial distribution, 11, 12 as well as nonparametric models 15, 16 and Bayesian methods. 13, 14 Table 2 summarizes all the reviewed methods in this paper.
For readers who are interested in the performance evalu ation and method comparison of the available methods, they can refer to the original paper as well as the body of litera ture on this issue. For instance, in the study by Seyednasrollah et al. 22 , DESeq has been recommended as one of the most robust methods and caution is advised when dealing with a small number of replicates regardless of which method is being used. Similarly, Soneson and Delorenzi 21 also advise caution when interpreting results drawn from a small number of rep licates and show that SAMseq surpasses many other reviewed methods. In the study by Rapaport et al. 23 , DESeq, edgeR, and baySeq, which all assume a negative binomial model, have bet ter specificity, sensitivity, and control of false positive errors than other nonnegative binomial models. As the technol ogy continues to improve and the empirical data accumulate, more compelling statistical modeling for RNAseq data can be expected.
